Executive summary Tuberculosis can be treated, prevented, and cured. Rapid, sustained
declines in tuberculosis deaths in many countries during the past 50 years provide …

Only 25% of multidrug-resistant tuberculosis (MDR-TB) cases are currently diagnosed. Line
probe assays (LPAs) enable rapid drug-susceptibility testing for rifampicin (RIF) and …

BACKGROUND: Drug-resistant tuberculosis (TB), especially multidrug-resistant (MDR,
resistance to rifampicin and isoniazid) disease, is associated with a worse patient outcome …

Background Multi drug resistant tuberculosis (MDR-TB) poses formidable challenges to TB
control due to its complex diagnostic and treatment challenges and often associated with a …

Tuberculosis (TB) is an infectious disease that remains an important public health problem
at the global level. It is one of the main causes of morbidity and mortality, due to the …

Background The objectives of the study were to compare the performance of line probe
assay (GenoType MTBDR plus) with solid culture method for an early diagnosis of multidrug …

Background There is an urgent demand for rapid and accurate drug-susceptibility testing for
the detection of multidrug-resistant tuberculosis. The GenoType MTBDR plus assay is a …

In this review, we describe the phenotypic and genotypic methods currently available for the
diagnosis of TB and drug-resistant forms of Mycobacterium tuberculosis and discuss future …

Background Xpert MTB/RIF is an automated cartridge-based nucleic acid amplification test
that has demonstrated its potential to detect tuberculosis and rifampicin resistance with high …

This is an exciting time for tuberculosis (TB) diagnostics. The technology for rapid diagnosis
of TB and rifampicin (RMP) resistance in pulmonary sputum smear-positive specimens is …